Your browser doesn't support javascript.
Periodically aperiodic pattern of SARS-CoV-2 mutations underpins the uncertainty of its origin and evolution.
Hassan, Sk Sarif; Basu, Pallab; Redwan, Elrashdy M; Lundstrom, Kenneth; Choudhury, Pabitra Pal; Serrano-Aroca, Ángel; Azad, Gajendra Kumar; Aljabali, Alaa A A; Palu, Giorgio; Abd El-Aziz, Tarek Mohamed; Barh, Debmalya; Uhal, Bruce D; Adadi, Parise; Takayama, Kazuo; Bazan, Nicolas G; Tambuwala, Murtaza M; Lal, Amos; Chauhan, Gaurav; Baetas-da-Cruz, Wagner; Sherchan, Samendra P; Uversky, Vladimir N.
  • Hassan SS; Department of Mathematics, Pingla Thana Mahavidyalaya, Maligram, Paschim Medinipur, 721140, West Bengal, India. Electronic address: sksarifhassan@pinglacollege.ac.in.
  • Basu P; School of Physics, University of the Witwatersrand, Johannesburg, Braamfontein 2000, 721140, South Africa. Electronic address: pallabbasu@gmail.com.
  • Redwan EM; Biological Science Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia; Therapeutic and Protective Proteins Laboratory, Protein Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications, New B
  • Lundstrom K; PanTherapeutics, Rte de Lavaux 49, CH1095, Lutry, Switzerland. Electronic address: lundstromkenneth@gmail.com.
  • Choudhury PP; Indian Statistical Institute, Applied Statistics Unit, 203 B T Road, Kolkata, 700108, India. Electronic address: pabitrapalchoudhury@gmail.com.
  • Serrano-Aroca Á; Biomaterials & Bioengineering Lab, Centro de Investigación Traslacional San Alberto Magno, Universidad Católica de Valencia, San Vicente Mártir, Valencia 46001, Spain. Electronic address: angel.serrano@ucv.es.
  • Azad GK; Department of Zoology, Patna University, Patna, Bihar, India. Electronic address: gkazad@patnauniversity.ac.in.
  • Aljabali AAA; Department of Pharmaceutics and Pharmaceutical Technology, Yarmouk University, Faculty of Pharmacy, Irbid, 566, Jordan. Electronic address: alaaj@yu.edu.jo.
  • Palu G; Department of Molecular Medicine, University of Padova, Via Gabelli 63, 35121, Padova, Italy. Electronic address: giorgio.palu@unipd.it.
  • Abd El-Aziz TM; Zoology Department, Faculty of Science, Minia University, El-Minia, 61519, Egypt; Department of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX, 78229-3900, USA. Electronic address: mohamedt1@uthscsa.edu.
  • Barh D; Centre for Genomics and Applied Gene Technology, Institute of Integrative Omics and Applied Biotechnology (IIOAB), Nonakuri, Purba Medinipur, WB, India; Departamento de Genetica, Ecologia e Evolucao, Instituto de Cîencias Biologicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais
  • Uhal BD; Department of Physiology, Michigan State University, East Lansing, MI, 48824, USA. Electronic address: bduhal@gmail.com.
  • Adadi P; Department of Food Science, University of Otago, Dunedin, 9054, New Zealand. Electronic address: pariseadadi@gmail.com.
  • Takayama K; Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, 6068507, Japan. Electronic address: kazuo.takayama@cira.kyoto-u.ac.jp.
  • Bazan NG; Neuroscience Center of Excellence, School of Medicine, LSU Health New Orleans, New Orleans, LA, 70112, USA. Electronic address: nbazan@lsuhsc.edu.
  • Tambuwala MM; School of Pharmacy and Pharmaceutical Science, Ulster University, Coleraine, BT52 1SA, Northern Ireland, UK. Electronic address: m.tambuwala@ulster.ac.uk.
  • Lal A; Department of Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA. Electronic address: manavamos@gmail.com.
  • Chauhan G; School of Engineering and Sciences, Tecnologico de Monterrey, Av. Eugenio Garza Sada 2501 Sur, 64849, Monterrey, Nuevo Léon, Mexico. Electronic address: gchauhan@tec.mx.
  • Baetas-da-Cruz W; Translational Laboratory in Molecular Physiology, Centre for Experimental Surgery, College of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil. Electronic address: wagner.baetas@gmail.com.
  • Sherchan SP; Department of Environmental Health Sciences, Tulane University, New Orleans, LA, 70112, USA. Electronic address: sshercha@tulane.edu.
  • Uversky VN; Department of Molecular Medicine and USF Health Byrd Alzheimer's Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, 33612, USA; Research Center for Molecular Mechanisms of Aging and Age-Related Diseases, Moscow Institute of Physics and Technology, Institutskiy pereulok,
Environ Res ; 204(Pt B): 112092, 2022 03.
Article in English | MEDLINE | ID: covidwho-1433211
ABSTRACT
Various lineages of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) have contributed to prolongation of the Coronavirus Disease 2019 (COVID-19) pandemic. Several non-synonymous mutations in SARS-CoV-2 proteins have generated multiple SARS-CoV-2 variants. In our previous report, we have shown that an evenly uneven distribution of unique protein variants of SARS-CoV-2 is geo-location or demography-specific. However, the correlation between the demographic transmutability of the SARS-CoV-2 infection and mutations in various proteins remains unknown due to hidden symmetry/asymmetry in the occurrence of mutations. This study tracked how these mutations are emerging in SARS-CoV-2 proteins in six model countries and globally. In a geo-location, considering the mutations having a frequency of detection of at least 500 in each SARS-CoV-2 protein, we studied the country-wise percentage of invariant residues. Our data revealed that since October 2020, highly frequent mutations in SARS-CoV-2 have been observed mostly in the Open Reading Frame (ORF) 7b and ORF8, worldwide. No such highly frequent mutations in any of the SARS-CoV-2 proteins were found in the UK, India, and Brazil, which does not correlate with the degree of transmissibility of the virus in India and Brazil. However, we have found a signature that SARS-CoV-2 proteins were evolving at a higher rate, and considering global data, mutations are detected in the majority of the available amino acid locations. Fractal analysis of each protein's normalized factor time series showed a periodically aperiodic emergence of dominant variants for SARS-CoV-2 protein mutations across different countries. It was noticed that certain high-frequency variants have emerged in the last couple of months, and thus the emerging SARS-CoV-2 strains are expected to contain prevalent mutations in the ORF3a, membrane, and ORF8 proteins. In contrast to other beta-coronaviruses, SARS-CoV-2 variants have rapidly emerged based on demographically dependent mutations. Characterization of the periodically aperiodic nature of the demographic spread of SARS-CoV-2 variants in various countries can contribute to the identification of the origin of SARS-CoV-2.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Experimental Studies Topics: Variants Limits: Humans Language: English Journal: Environ Res Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Experimental Studies Topics: Variants Limits: Humans Language: English Journal: Environ Res Year: 2022 Document Type: Article